Elekta (OTCMKTS:EKTAY) Sees Unusually-High Trading Volume – Here’s What Happened

Shares of Elekta AB (OTCMKTS:EKTAY) saw strong trading volume on Monday . 4,966 shares traded hands during trading, an increase of 107% from the previous session’s volume of 2,403 shares.The stock last traded at $4.9550 and had previously closed at $5.0250.

Analysts Set New Price Targets

Separately, Zacks Research lowered Elekta from a “hold” rating to a “strong sell” rating in a report on Tuesday, June 2nd. Two equities research analysts have rated the stock with a Sell rating, Based on data from MarketBeat.com, Elekta currently has an average rating of “Sell”.

Elekta Stock Performance

The stock has a market cap of $1.81 billion, a price-to-earnings ratio of -30.62 and a beta of 1.00. The business’s fifty day simple moving average is $5.85 and its 200 day simple moving average is $6.05. The company has a debt-to-equity ratio of 0.56, a current ratio of 0.95 and a quick ratio of 0.73.

Elekta (OTCMKTS:EKTAY) last released its earnings results on Thursday, May 28th. The company reported $0.06 earnings per share for the quarter. The firm had revenue of $521.00 million during the quarter. Elekta had a negative net margin of 3.32% and a positive return on equity of 10.67%. On average, research analysts predict that Elekta AB will post 0.43 EPS for the current year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.